Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 12

Epidermolytic hyperkeratosis: clinical update

Authors Peter Rout D, Nair A, Gupta A, Kumar P

Received 15 October 2018

Accepted for publication 1 April 2019

Published 8 May 2019 Volume 2019:12 Pages 333—344

DOI https://doi.org/10.2147/CCID.S166849

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Jeffrey Weinberg


Denice Peter Rout,* Anushka Nair,* Anand Gupta, Piyush Kumar

Amity Institute of Biotechnology, Amity University Mumbai, Navi Mumbai, India

*These authors contributed equally to this work


Abstract: Epidermolytic hyperkeratosis (EHK), earlier termed as bullous congenital ichthyosiform erythroderma is a skin disorder characterized as an autosomal dominant and rare disorder which has been observed to affect 1 in over 200,000 infants as a consequence of a significant mutation in the genes responsible for the keratin proteins, mostly keratin 1 and 10. The features present at birth include erythema and blistering. In adults, the hallmarks include hyperkeratosis, erosions, and blisters. The major symptoms including xerosis, pruritus, and painful fissuring lead not only to cosmetic problems but also stress, inferiority complex and other psychological conditions. While clinical inspection followed by confirmatory tests including histopathology and electron microscopic assessment is used for diagnosis, treatment modalities can be further improved for better diagnosis. This article reviews subtypes of ichthyosis, with a focus on EHK, genetics behind the disease, recently reported mutations, the existing diagnostics and treatments for the same and potential of new modalities in diagnosis/treatment.

Keywords: epidermolytic hyperkeratosis, ichthyosis, skin, skin disorder

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]